Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

In vivo neuroprotective effects of NNZ-2566

Nov. 15, 2005

XIAP gene therapy for motor neuron diseases

Nov. 14, 2005

SSR-180575 ameliorates the neurodegenerative effects of FALS

Nov. 14, 2005

Femtomolar concentrations of DPI protect against inflammation and neurotoxicity in vitro

Nov. 14, 2005

ProEthic holds pre-IND meetings for fast-acting diclofenac products

Nov. 14, 2005

Cellegy amends European licensing agreement for Rectogesic with ProStrakan

Nov. 14, 2005

Pain Therapeutics and King sign agreement for Remoxy

Nov. 14, 2005

SELENBP1 identified as candidate gene for schizophrenia using novel approach

Nov. 11, 2005

Recent patents cover novel treatments for neurological disorders

Nov. 11, 2005

European approval for Zeldox for manic or mixed episodes in bipolar disorder

Nov. 11, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...